Gilat M, Coeytaux Jackson A, Marshall NS, Hammond D, Mullins AE, Hall JM, et al. Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: A randomised controlled trial. Mov Disord 2020;35(2):344–9. https://www.ncbi.nlm.nih.gov/pubmed/31674060
Hogl B, Stefani A, Videnovic A. Idiopathic REM sleep behaviour disorder and neurodegeneration - an update. Nat Rev Neurol 2018;14(1):40–55. https://www.ncbi.nlm.nih.gov/pubmed/29170501
Iranzo A, Santamaria J, Tolosa E. Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. Lancet Neurol 2016;15(4):405–19. https://www.ncbi.nlm.nih.gov/pubmed/26971662
McGrane IR, Leung JG, St Louis EK, Boeve BF. Melatonin therapy for REM sleep behavior disorder: a critical review of evidence. Sleep Med 2015;16(1):19–26. https://www.ncbi.nlm.nih.gov/pubmed/25454845
Morgenthaler TI, Auerbach S, Casey KR, Kristo D, Maganti R, Ramar K, et al. Position paper for the treatment of nightmare disorder in adults: an American Academy of Sleep Medicine position paper. J Clin Sleep Med 2018;14(6):1041–55. https://www.ncbi.nlm.nih.gov/pubmed/29852917
Wilson S, Anderson K, Baldwin D, Dijk DJ, Espie A, Espie C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J Psychopharmacol 2019;33(8):923–47. https://www.ncbi.nlm.nih.gov/pubmed/31271339
